Takahiro Nagai
Overview
Explore the profile of Takahiro Nagai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagahashi M, Ishikawa E, Nagai T, Kanaoka H, Oshiro A, Togashi Y, et al.
Breast Cancer
. 2025 Jan;
32(2):404-415.
PMID: 39808396
Purpose: The aim of this study was to examine the clinical utility of tumor-infiltrating lymphocytes (TILs) evaluated by "average" and "hot-spot" methods in breast cancer patients. Methods: We examined 367...
2.
Katsumi T, Hayashi R, Takei S, Ansai O, Takatsuka S, Takenouchi T, et al.
J Dermatol
. 2024 Nov;
51(11):1461-1469.
PMID: 39487562
Schwannomas consist of both high-cellularity regions (Antoni A area) and hypocellular regions (Antoni B area) in histopathological findings. Neurofibromas characteristically consist of CD34 positive spindle cells with thin, wavy, nuclei...
3.
Kawasaki M, Kawasaki K, Sari F, Kudo T, Nihara J, Kitamura M, et al.
Elife
. 2024 Oct;
13.
PMID: 39392396
Dysfunction of primary cilia leads to genetic disorder, ciliopathies, which shows various malformations in many vital organs such as brain. Multiple tongue deformities including cleft, hamartoma, and ankyloglossia are also...
4.
Ueno T, Kiwaki T, Betsunoh H, Ito K, Murashima T, Fujii M, et al.
J Med Case Rep
. 2024 Aug;
18(1):396.
PMID: 39192344
Introduction: Metastasis of malignant melanoma to urinary tract is reported to be rare. According to retrospective analysis of a single center study, improvement of overall survival was observed in patients...
5.
Iguchi H, Akamatsu H, Hirai Y, Nakaya T, Fusamoto A, Yata Y, et al.
Respirol Case Rep
. 2024 Aug;
12(8):e70007.
PMID: 39161537
Neoadjuvant therapy with nivolumab improves event-free survival (EFS) in patients with resectable non-small cell lung cancer, and a pathological complete response is a predictor of longer EFS. We assessed metabolic...
6.
Nakaya T, Hirai Y, Akamatsu H, Kojima F, Iguchi H, Fusamoto A, et al.
Respirol Case Rep
. 2024 Apr;
12(5):e01358.
PMID: 38680669
The standard treatment for resectable non-small cell lung cancer (NSCLC) located in the superior sulcus is neoadjuvant chemoradiotherapy followed by highly invasive resection. Based on the results of the CheckMate...
7.
Murashima T, Kida K, Gi T, Hida T, Fujii M, Nagai T, et al.
J Med Case Rep
. 2024 Apr;
18(1):170.
PMID: 38600580
Introduction: Paratesticular cellular angiofibroma is a rare benign mesenchymal tumor. The optimal management is surgical resection due to the difficulty of preoperative accurate diagnosis. Case Presentation: A 51-year-old Japanese male...
8.
Ozeki H, Shimada Y, Nakano M, Kondo S, Ohashi R, Miwa Y, et al.
Hum Pathol
. 2024 Feb;
145:71-79.
PMID: 38423222
Colorectal cancer (CRC) is a heterogeneous disease that develops through stepwise accumulation of genetic alterations and progresses via several distinct pathways. However, the tumorigenesis of CRCs with BRAF non-V600E mutations...
9.
Miyamoto Y, Kawasoe C, Ito K, Oguri N, Murashima T, Kamibeppu T, et al.
J Med Case Rep
. 2023 Dec;
17(1):524.
PMID: 38129899
Introduction: Methotrexate induces lymphoproliferative disorders on rare occasions; however, its pathogenesis remains unknown. A clinical diagnosis based on imaging studies alone is often difficult. Case Presentation: A 57-year-old Japanese woman...
10.
Kawasoe C, Miyamoto Y, Ito K, Murashima T, Nagai T, Takamori H, et al.
Res Rep Urol
. 2023 Oct;
15:447-452.
PMID: 37818232
Epithelioid angiomyolipoma (EAML) is a rare variant of AML with malignant potential. It is occasionally difficult to distinguish EAML from renal cell carcinoma (RCC) on imaging. A 72-year-old woman was...